#scleroderma نتائج البحث
#Scleroderma specific autoantibodies in predicting prognosis/survival ➡️ almost all #ANA positive 📈 Best survival in anticentromere group 📉 Diffuse subtype carries a worse prognosis especially Anti-Scl70, anti-RNA polymerase III & If 🫁 ILD present [AL Herrick]
Exploring the intersection of #Scleroderma and #GAVE — uncovering key demographic and mortality trends from a national inpatient analysis. Honored to share our findings at #ACR2025! #RheumResearch
Biologic Therapy for Refractory Juvenile Scleroderma” by Dr. Munirah Al Marri was accepted at #ACR25 – Chicago 🇺🇸! The world’s main rheumatology conference, covering both adult & pediatric advances. A proud step forward in improving care for young patients. #Scleroderma…
🏆 Meet the 2025 Major & Starting Grant winners from @WSF_Scleroderma! 👏 Their work drives research & hope for the #Scleroderma community. 🎧 Listen to Voices from SSc – Ep.1 🔗 Register free: worldsclerofound.org/register/ #WSFAcademy #SSc #Research #ILD
World experts in #scleroderma Drs. Bottini and Assassi met up to moderate an excellent session at #ACR25 !
Dr. Zsuzsanna McMahan presenting her very important novel research on autoantibodies in scleroderma patients with GI dysfunction. Thank you for all of your work in this critical field! #ACR25 #Rheumatology #scleroderma
Excited to present WIN #scleroderma #eular2025. This slide highlights the opportunities in drug development in SSc. Come and join on Saturday 6/14 at 9 AM CET.
🆕#EULAR 2024 recommendations for treatment of #SystemicSclerosis #Scleroderma slide produced by @RheumNow #ILD #Raynauds #pulmonaryhypertension #DigitalUlcers
A lot of enthusiasm about CAR-T therapy in #scleroderma. Data from Phase 1 trial sclerodermanews.com/news/car-t-cel…
#SCTC #scleroderma #ACR25 Lots of productive grants for investigators and trainees @ACRheum @RheumNow
🆕 @RheumatologyUK 2024 #SystemicSclerosis guidelines academic.oup.com/rheumatology/a… By Prof Chris Denton &Colleagues #scleroderma #PAH #ILD #Raynauds #arthritis
Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma
🧵1/ 👁 Ever wanted to see autoimmune Microvascular dysfunction in action? Nailfold Videocapillaroscopy (NVC) gives us a live look into systemic vascular health. A powerful, non-invasive window for early diagnosis in CTDs. Let’s walk through what it reveals in #Scleroderma.…
2 years ago,I was invited onto @BBCSheffield Paulette's show to talk about my #scleroderma I've kindly been invited back on to talk about allsorts this Wednesday morning! Wish me luck !!
🆕CD19 CAR T Cell treatment -A potentially promising future treatment in #SLE #scleroderma #myositis -Needs close collaboration with haematology Great explanation by @chriswincup #ACR24 #Lupus #SystemicSclerosis #IIM
Excited to present data from RESET-SSc in #scleroderma #eular2025. CAR-T was well tolerated with beneficial effects on skin/ FVC. Exciting data on U-M IIS with LN bx showing complete depletion of B cells at 3 weeks and NFC showing normalization of capillary density and size
While NSIP & UIP are common patterns on HRCT, COP, LIP & DIP can occur in #Scleroderma-ILD. Neither NSIP nor UIP are independent predators of survival. @HanaRheum #EULAR2025
🏆 Meet the 2025 Major & Starting Grant winners from @WSF_Scleroderma! 👏 Their work drives research & hope for the #Scleroderma community. 🎧 Listen to Voices from SSc – Ep.1 🔗 Register free: worldsclerofound.org/register/ #WSFAcademy #SSc #Research #ILD
Exploring the intersection of #Scleroderma and #GAVE — uncovering key demographic and mortality trends from a national inpatient analysis. Honored to share our findings at #ACR2025! #RheumResearch
UT Houston #Rheumatology division welcomes Dr. Jörg Distler who shared his incredible work regarding molecular profiling of fibroblasts in #scleroderma. Thank you for your insights and all of your efforts!
World experts in #scleroderma Drs. Bottini and Assassi met up to moderate an excellent session at #ACR25 !
A lot of enthusiasm about CAR-T therapy in #scleroderma. Data from Phase 1 trial sclerodermanews.com/news/car-t-cel…
Our article on localized #scleroderma is out in BJD. Thank you all coauthors! Localized scleroderma and related comorbidities: a single centre cohort study | British Journal of Dermatology | Oxford Academic academic.oup.com/bjd/advance-ar…
academic.oup.com
Localized scleroderma and related comorbidities: a single centre cohort study
This single-center cohort study examined 155 patients with localized scleroderma (morphea) in Southwest Finland, highlighting a predominance in females and
Primary Raynaud's is not correlated with any underlying medical condition, whereas secondary Raynaud's is causally connected to another medical condition, such as #scleroderma or #lupus. Read more, here: bit.ly/3bL8xkT #raynaudsphenomenon #frosties
#ACR25: Mary Alore, #Scleroderma patient and advocate, speaking Oct. 28 at the 2025 @ACRheum Convergence in Chicago about #CognitiveDysfunction or “brain fog” in #RheumaticDiseases. Image & quote taken by Senior Correspondent, @LLuxner #RareDisease #Rheumatology #BrainFog
Join us at clinical trial booth #972 at @ACRheum 2025 to learn more about the RESOLUTION trial, our investigational dual-targeted CD19/CD70 allogeneic CAR T for adults with #lupus, #myositis, and #scleroderma. $ALLO
Dr. Zsuzsanna McMahan presenting her very important novel research on autoantibodies in scleroderma patients with GI dysfunction. Thank you for all of your work in this critical field! #ACR25 #Rheumatology #scleroderma
Primary Raynaud's is not correlated with any underlying medical condition, whereas secondary Raynaud's is causally connected to another medical condition, such as #scleroderma or #lupus. Read more, here: bit.ly/3bL8xkT #raynaudsphenomenon #frosties
#SCTC #scleroderma #ACR25 Lots of productive grants for investigators and trainees @ACRheum @RheumNow
Join expert rheumatologists from @NorthwesternMed for the Scleroderma Educational Event on October 24. This event will explore the latest developments in #scleroderma research and management from a multidisciplinary perspective. Learn more and register now:…
Did you know around 20% of people with #scleroderma also have #lupus? 💜 These crossover conditions show why awareness and early detection matter. This #NationalAwarenessMonth, let’s shine a light on this condition and those living with it.
Outstanding talk on #scleroderma and Nail fold video capillaroscopy by @AshimaMakol @MayoClinic #STIR24
#Scleroderma specific autoantibodies in predicting prognosis/survival ➡️ almost all #ANA positive 📈 Best survival in anticentromere group 📉 Diffuse subtype carries a worse prognosis especially Anti-Scl70, anti-RNA polymerase III & If 🫁 ILD present [AL Herrick]
#scleroderma 1. why is SSc- a 'fibrotic disease' treated with immunosuppressive? 2. Why dont every patient with early SSc respond to immunosuppressive? the lessons lie in understanding the underlying mechanisms of early SSc and molecular heterogeneity. @IRACON24Blr
🆕#EULAR 2024 recommendations for treatment of #SystemicSclerosis #Scleroderma slide produced by @RheumNow #ILD #Raynauds #pulmonaryhypertension #DigitalUlcers
Dr. Zsuzsanna McMahan presenting her very important novel research on autoantibodies in scleroderma patients with GI dysfunction. Thank you for all of your work in this critical field! #ACR25 #Rheumatology #scleroderma
🆕 @RheumatologyUK 2024 #SystemicSclerosis guidelines academic.oup.com/rheumatology/a… By Prof Chris Denton &Colleagues #scleroderma #PAH #ILD #Raynauds #arthritis
🏆 Meet the 2025 Major & Starting Grant winners from @WSF_Scleroderma! 👏 Their work drives research & hope for the #Scleroderma community. 🎧 Listen to Voices from SSc – Ep.1 🔗 Register free: worldsclerofound.org/register/ #WSFAcademy #SSc #Research #ILD
World experts in #scleroderma Drs. Bottini and Assassi met up to moderate an excellent session at #ACR25 !
Exploring the intersection of #Scleroderma and #GAVE — uncovering key demographic and mortality trends from a national inpatient analysis. Honored to share our findings at #ACR2025! #RheumResearch
Excited to present WIN #scleroderma #eular2025. This slide highlights the opportunities in drug development in SSc. Come and join on Saturday 6/14 at 9 AM CET.
#Scleroderma organ specific associated antibodies. #systemicsclerosis & Antibodies associated w/overlap SSc Extracted from Textbook Scleroderma From Pathogenesis to Comprehensive management 2024 #Rheumatology #MedTwitter 👇
#Scleroderma mimics From Textbook Scleroderma From Pathogenesis to Comprehensive management. Chapter 11 (Hummers et Tyndall) 2024 👇 #Rheumatology #MedTwitter
Prophylactic ACEi in #Scleroderma? No benefit, worse outcomes in renal crisis! #Rheumatology #MedTwitter #BSR25
Great @SmidtHeart #research seminar by X. Mike Jones. Lead #ncRNA compound TY1 reverses the key manifestations of #scleroderma in two complementary mouse models! It even works orally. Next goal: first-in-human studies in #systemicsclerosis patients! @CedarsSinaiMed
Hey everyone! Today is #WorldSclerodermaDay I’m raising awareness about this debilitating disease! I’m in my 4th year. Don’t give up hope! We will find a cure. I’m happy to be thriving. Thanks for the love! ❤️🙏🏼#scleroderma
Bang-up @MarbanLab mtg presentation by @nih_nhlbi #T32 fellow @XMichaelJonesMD gives new hope for #scleroderma. In two #mouse models and human #SSc #macrophages (🙏@fboinMD), #ncRNA drug TY1 attenuates #DNAdamage and reverses disease. 👍. Thanks Mike for your great work!…
Dr. Aos Aboabat, #Scleroderma Clinical Research Fellow @SchroederInst, supervised by Dr. @SindhuJohnson5, presented his research at the Rheumatology Ogryzlo Research Day @UofT and will be graduating this year! #WorldSclerodermaDay
Something went wrong.
Something went wrong.
United States Trends
- 1. VMIN 14.4K posts
- 2. Good Saturday 17.7K posts
- 3. seokjin 218K posts
- 4. Chovy 11.3K posts
- 5. Nigeria 452K posts
- 6. Spring Day 45.6K posts
- 7. #SaturdayVibes 2,837 posts
- 8. GenG 6,208 posts
- 9. #LoVeMeAgain 26.8K posts
- 10. VOCAL KING TAEHYUNG 29K posts
- 11. Happy New Month 210K posts
- 12. #AllSaintsDay 1,140 posts
- 13. Merry Christmas 11.3K posts
- 14. #Worlds2025 38.1K posts
- 15. Game 7 77.9K posts
- 16. Shirley Temple 1,036 posts
- 17. #Jin_TOUR_ENCORE 313K posts
- 18. jungkook 629K posts
- 19. Tinubu 49.9K posts
- 20. Wrigley N/A